• IPO structure: Prasol Chemicals is raising ₹500 crore at a price band of ₹643 to ₹676 per share, comprising a fresh issue of approximately ₹80 crore alongside an offer for sale.
• Revenue diversification: Domestic sales contribute 75% and exports generate 25% across 69 countries, with the top 10 clients accounting for under 22% of total volume and the single largest customer delivering ₹50 crore out of ₹1,200 crore in sales.
• Self-funded expansion: Ongoing expansions are funded primarily through internal cash generation and reinvestment rather than debt or fresh equity, supported by higher EBITDA margins from advanced acetone and phosphorus derivatives.
• Capacity expansion: Manufacturing capacity grew from roughly 70,000 tonnes three years ago to around 1 lakh tonnes today, operating at about 75% utilization with a focus on low-capex debottlenecking and import substitution.
• Financial turnaround: Following a past operational disruption at its Mahad facility, automation and global quality certifications enabled a 50% increase in revenue and 45% EBITDA growth over a three-year period.